Search Drug Alphabetically
||Medicare Part D
|Type of Drug
||Retinoid X receptor activator
- For the treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy. (7/29/15)
|Approved Indication(s) with Orphan Drug Status
||Treatment of cutaneous T-cell lymphoma.
|ICD-10 Code(s) for Labeled Indication(s)
||Mature T/NK-cell lymphomas [C84.xx]
Copyright © 2021 Association of Community Cancer Centers. All Rights Reserved.
11600 Nebel Street, Suite 201, Rockville, MD 20852 | Tel.: 301.984.9496 | Fax: 301.770.1949